ARCHIVES

NCI Clarifies IRPG Application Receipt, Funding Policies

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985